x
Filter:
Filters applied
- JAH_Position_Papers
- Breuner, Cora CRemove Breuner, Cora C filter
- Middleman, Amy BRemove Middleman, Amy B filter
- Ipp, Lisa SRemove Ipp, Lisa S filter
SAHM Position & Statement Papers
1 Results
- Position statement
Meningococcal Vaccine: A Position Statement of the Society for Adolescent Health and Medicine
Journal of Adolescent HealthVol. 50Issue 2p211–212Published in issue: February, 2012- Lisa S. Ipp
- Cora C. Breuner
- Amy B. Middleman
- SAHM Committee on Adolescent Vaccination
Cited in Scopus: 0Although rates of meningococcal disease have remained low in the United States since 2000, the severity of the disease, rapidity with which it strikes, and significant sequelae remain compelling reasons to employ all means possible to prevent it. Meningococcal disease has a bimodal peak distribution in the United States with its highest incidence rates in infants and adolescents aged 16 years and older. The 2005 recommendations from the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention were intended to protect youth entering adolescence including individuals 16–21 years of age, the ages at which meningococcal disease rates peak for children and young adults.
